Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: FEVER; INJECTION SITE PAIN IN LEFT ARM; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; OFF LABEL USE; This spontaneous report received from a pharmacist concerned an adolescent female. The patient''s height, and weight were not reported. The patient''s pre-existing medical conditions included unknown. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 03-JUN-2021, the subject experienced product administered to subject of inappropriate age. On 03-JUN-2021, the subject experienced off label use. On 05-JUN-2021, the subject experienced fever. On 05-JUN-2021, the subject experienced injection site pain in left arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, injection site pain in left arm, product administered to patient of inappropriate age and off label use was not reported. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166